Address And Details

PO Box 55932 , Boston, MA 02205-5932
Fund Manager Andrew Acker
Manager Tenure 12 Years 2 Months

Strategy And Objective

Janus Henderson Global Life Sciences Fund seeks long-term growth of capital. The Fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio manager believes have a life science orientation. In the Fund s pursuit of companies with a life science orientation, the Fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the life sciences sector, which may include companies in the following industry groups: pharmaceutical; biotechnology; health care services; and medical devices. Generally speaking, the life sciences relate to maintaining or improving quality of life. So, for example, companies with a life science orientation include companies engaged in research, development, production, or distribution of products or services related to health and personal care, medicine, or pharmaceuticals. The Fund implements its investment policies by investing primarily in equity securities of U.S. and foreign companies selected for their growth potential. The Fund normally invests in issuers from several different countries, which may include the United States. The Fund may, under unusual circumstances, invest in a single country. The Fund may have exposure to emerging markets. The Fund may invest in shares of companies through initial public offerings. The portfolio manager applies a bottom up approach in choosing investments. In other words, the portfolio manager looks at companies one at a time to determine if a company is an attractive investment opportunity and if it is consistent with the Fund s investment policies. The Fund may lend portfolio securities on a short-term or long-term basis, in an amount equal to up to one-third of its total assets as determined at the time of the loan origination.

Net Asset Value

as of 5:46 PM ET 09/17/2021

Performance

  • 1 Week
  • +0.15%
  • 1 Month
  • +0.87%
  • 3 Months
  • +3.13%
  • 1 Yr Return
  • +11.40%
  • 5 Yr Return
  • +50.12%

Equity Sector Breakdown

Health 61.56%
Finance 10.49%
Services 9.82%
Technology 5.59%
IndustrialCyclical 5.52%
ConsumerDurables n/a
Energy n/a
NonDurables n/a
RetailTrade n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Stocks 97.42%
ForeignStocks 19.93%
Preferred 2.06%
Cash 0.00%
Bonds 0.00%
Convertible 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 295.56 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha 0.64 0.62 4.59
Beta 0.80 0.83 0.87
R Squared 0.73 0.65 0.55
Std Deviation 17.36 15.49 15.68
Sharpe Ratio 0.89 1.00 n/a

Purchase Information

as of 5:45 PM ET 09/16/2021
Minimum Initial $2500
Minimum Additional $0
Minimum Initial IRA $500

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +21.83%
  • +24.99%
+21.83% +24.99%
3 Year
  • +15.04%
  • +17.16%
+15.04% +17.16%
10 Year
  • +18.79%
  • +17.46%
+18.79% +17.46%
Life Of Fund
  • +18.22%
  • +18.17%
+18.22% +18.17%

Top 10 Holdings

Symbol Company Name % Of Assets
AZN:LN ASTRAZENECA PLC 4.49%
UNH UNITEDHEALTH GROUP INC 3.97%
ROG ROCHE HOLDING AG 2.91%
ABBV ABBVIE INC 2.80%
MRK MERCK & CO 2.75%
NVS NOVARTIS AG ADR 2.58%
HUM HUMANA INC 2.46%
BSX BOSTON SCIENTIFIC CORP 2.45%
ABT ABBOTT LABORATORIES 2.29%
TMO THERMO FISHER SCIENTIFIC INC 2.28%

LATEST NEWS

Recent Articles from TheStreet

Hong Kong Stocks Slump On Tech Sector Worries As US Official Signals Flaws In China Trade Deal

Intraday Reversals Signal Struggles for Market

But James "Rev Shark" Deporre says the trading action is both normal, and appropriate for September, and he's been adding some names to his portfolio.

stocks market index sh

Cramer's Mad Money Recap: FedEx, Costco, Nike

Jim Cramer says this is a rough season for stock, and investors need to take defensive action.

anxiety grocery mask sh

Jensen: Economy Has a Bearish Outlook

Real Money's Bret Jensen says a slower-than-expected pandemic recovery is a warning for the stock market.

Pfizer vaccine Lead

FDA Panel Recommends Covid Booster Shots for 65, Older and Those at High Risk

Food and Drug Administration's advisory panel on Friday voted to recommend Covid-19 booster shots of the Pfizer vaccine for a limited section of the population.

Ford Lead

Stock Market Today With Jim Cramer: How to Trade Ford

Jim Cramer discusses Ford and the impact of the impending tax policy changes on the stock market.

Jim Cramer: Stay Long Thermo Fisher, Sell FEI

Thermo Fisher Climbs on Strong 2022 Guidance

Thermo Fisher expects revenue to increase 12% year over year next year to $40.3 billion.